Literature DB >> 25782447

Dynamic Autoregulatory Response After Aneurysmal Subarachnoid Hemorrhage and Its Relation to Angiographic Vasospasm and Clinical Outcome.

Johann Fontana1, Julius Moratin2, Gregory Ehrlich2, Johann Scharf3, Christel Weiß4, Kirsten Schmieder5, Martin Barth6.   

Abstract

BACKGROUND: Impaired cerebral autoregulation (CA) is increasingly recognized to contribute to sequelae after aneurysmal subarachnoid hemorrhage (SAH). The current study characterizes the course of the dynamic autoregulation index (ARI) during the first 8 days after SAH and its coherence with angiographic vasospasm (VS) and clinical outcome.
METHODS: Fifty-one patients with SAH were prospectively included within 48 h after the ictus. The ARI was determined daily for each hemisphere with the thigh cuff test. The degree of cerebral VS was evaluated based on a baseline digital subtraction angiography (DSA) after the ictus and a follow-up DSA on day 8. The clinical outcome was determined by the Modified Rankin Scale (mRS), the Glasgow Outcome Scale Extended (GOSE), and the National Institute of Health Stroke Scale (NIHSS) at discharge from the intensive care unit.
RESULTS: Impaired CA significantly correlated with unfavorable clinical outcome scores (mRS, p = 0.0021; GOSE, p = 0.0027; NIHSS, p = 0.0091). ARI-values of patients with a favorable clinical outcome (mRS 0-3) showed a significant improvement during the first 8 days (+0.1964/day; p = 0.0148) compared to a significant decrease of ARI-values in patients with an unfavorable clinical outcome (-0.2976/day; p = 0.0182). The degree of CA impairment significantly correlated with the severity of VS in the middle cerebral artery (p = 0.0184).
CONCLUSIONS: Early deterioration of CA significantly correlates with unfavorable clinical outcome and severity of angiographic vasospasm. Dynamic CA measurements might represent an important tool in stratifying therapy guidelines in patients after SAH.

Entities:  

Keywords:  Cerebral autoregulation; Cerebral vasospasm; Dynamic autoregulation index; Subarachnoid hemorrhage

Mesh:

Year:  2015        PMID: 25782447     DOI: 10.1007/s12028-014-0104-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  50 in total

1.  Continuous cerebral autoregulation monitoring by cross-correlation analysis.

Authors:  Ralf Steinmeier; Robby P Hofmann; Christian Bauhuf; Ulrich Hübner; Rudolf Fahlbusch
Journal:  J Neurotrauma       Date:  2002-10       Impact factor: 5.269

2.  Continuous assessment of cerebrovascular autoregulation after traumatic brain injury using brain tissue oxygen pressure reactivity.

Authors:  Matthias Jaeger; Martin U Schuhmann; Martin Soehle; Jürgen Meixensberger
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

3.  Reliability of dynamic cerebral autoregulation measurement using spontaneous fluctuations in blood pressure.

Authors:  Fiona G Brodie; Emily R Atkins; Thompson G Robinson; Ronney B Panerai
Journal:  Clin Sci (Lond)       Date:  2009-03       Impact factor: 6.124

4.  Dynamic autoregulatory response after severe head injury.

Authors:  Roman Hlatky; Yu Furuya; Alex B Valadka; Jorge Gonzalez; Ari Chacko; Yasu Mizutani; Charles F Contant; Claudia S Robertson
Journal:  J Neurosurg       Date:  2002-11       Impact factor: 5.115

5.  Dynamic cerebral autoregulation in patients with ruptured and unruptured aneurysms after induction of general anesthesia.

Authors:  K Schmieder; F Möller; M Engelhardt; M Scholz; W Schregel; A Christmann; A Harders
Journal:  Zentralbl Neurochir       Date:  2006-05

6.  Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction.

Authors:  Christian Dohmen; Bert Bosche; Rudolf Graf; Thomas Reithmeier; Ralf-Ingo Ernestus; Gerrit Brinker; Jan Sobesky; Wolf-Dieter Heiss
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

7.  Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity.

Authors:  E W Lang; R R Diehl; H M Mehdorn
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

8.  Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia.

Authors:  S Strebel; A M Lam; B Matta; T S Mayberg; R Aaslid; D W Newell
Journal:  Anesthesiology       Date:  1995-07       Impact factor: 7.892

9.  Cerebrovascular reactivity in patients with ruptured intracranial aneurysms.

Authors:  B Voldby; E M Enevoldsen; F T Jensen
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

10.  An assessment of dynamic autoregulation from spontaneous fluctuations of cerebral blood flow velocity: a comparison of two models, index of autoregulation and mean flow index.

Authors:  Marek Czosnyka; Piotr Smielewski; Andrea Lavinio; John D Pickard; Ronney Panerai
Journal:  Anesth Analg       Date:  2008-01       Impact factor: 5.108

View more
  15 in total

1.  The Link Between Cerebrovascular Hemodynamics and Rehabilitation Outcomes After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Forrest A Brooks; Uvieoghene Ughwanogho; Galen V Henderson; Randie Black-Schaffer; Farzaneh A Sorond; Can Ozan Tan
Journal:  Am J Phys Med Rehabil       Date:  2018-05       Impact factor: 2.159

2.  Pathophysiologic differences in cerebral autoregulation after subarachnoid hemorrhage.

Authors:  Gabriela A Santos; Nils Petersen; Amir A Zamani; Rose Du; Sarah LaRose; Andrew Monk; Farzaneh A Sorond; Can Ozan Tan
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

Review 3.  Cerebral Blood Flow Autoregulation in Sepsis for the Intensivist: Why Its Monitoring May Be the Future of Individualized Care.

Authors:  Carrie M Goodson; Kathryn Rosenblatt; Lucia Rivera-Lara; Paul Nyquist; Charles W Hogue
Journal:  J Intensive Care Med       Date:  2016-10-25       Impact factor: 3.510

4.  The effects of ventricular drainage on the intracranial pressure signal and the pressure reactivity index.

Authors:  Tim Howells; Ulf Johnson; Tomas McKelvey; Elisabeth Ronne-Engström; Per Enblad
Journal:  J Clin Monit Comput       Date:  2016-03-17       Impact factor: 2.502

Review 5.  Impact of Cerebral Autoregulation Monitoring in Cerebrovascular Disease: A Systematic Review.

Authors:  Mais Al-Kawaz; Sung-Min Cho; Rebecca F Gottesman; Jose I Suarez; Lucia Rivera-Lara
Journal:  Neurocrit Care       Date:  2022-04-05       Impact factor: 3.210

Review 6.  Review of studies on dynamic cerebral autoregulation in the acute phase of stroke and the relationship with clinical outcome.

Authors:  Ricardo C Nogueira; Marcel Aries; Jatinder S Minhas; Nils H Petersen; Li Xiong; Jana M Kainerstorfer; Pedro Castro
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-13       Impact factor: 6.960

7.  Spontaneous Elevation of Blood Pressure After SAH: An Epiphenomenon of Disease Severity and Demand, But Not a Surrogate for Outcome?

Authors:  F Teping; W Albanna; H Clusmann; H Schulze-Steinen; M Mueller; A Hoellig; G A Schubert
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

Review 8.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

Review 9.  Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation.

Authors:  Jurgen A H R Claassen; Dick H J Thijssen; Ronney B Panerai; Frank M Faraci
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 37.312

10.  Early Transcranial Doppler Evaluation of Cerebral Autoregulation Independently Predicts Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Carla B Rynkowski; Airton Leonardo de Oliveira Manoel; Marcelo Martins Dos Reis; Corina Puppo; Paulo Valdeci Worm; Diego Zambonin; Marino Muxfeldt Bianchin
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.